Cargando…
The efficacy and safety of apatinib in Ewing’s sarcoma: a retrospective analysis in one institution
BACKGROUND: Ewing’s sarcoma (ES) is a highly aggressive and metastatic neoplasm occurring mainly in children and young adults. The standard treatment of localized ES requires a combination of surgery, chemotherapy, and radiotherapy. Although the 5-year survival rate for local ES has improved, the su...
Autores principales: | Wang, Yitian, Min, Li, Zhou, Yong, Luo, Yi, Duan, Hong, Tu, Chongqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294078/ https://www.ncbi.nlm.nih.gov/pubmed/30588089 http://dx.doi.org/10.2147/CMAR.S181087 |
Ejemplares similares
-
The efficacy and safety of apatinib in metastatic alveolar soft part sarcoma: a case series of six patients in one institution
por: Wang, Yitian, et al.
Publicado: (2019) -
The Efficacy and Safety of Apatinib in Advanced Synovial Sarcoma: A Case Series of Twenty-One Patients in One Single Institution
por: Wang, Yitian, et al.
Publicado: (2020) -
Activity and safety of apatinib monotherapy or apatinib combined with chemotherapy for patients with metastatic or unresectable osteosarcoma over the age of 40 years: A retrospective analysis
por: Gong, Taojun, et al.
Publicado: (2022) -
Advanced alveolar soft part sarcoma responds to apatinib
por: Zhou, Yong, et al.
Publicado: (2017) -
The Activity and Safety of Anlotinib for Patients with Extremity Desmoid Fibromatosis: A Retrospective Study in a Single Institution
por: Zheng, Chuanxi, et al.
Publicado: (2020)